| Product NDC: | 68220-144 |
| Proprietary Name: | Epifoam |
| Non Proprietary Name: | hydrocortisone acetate and pramoxine hydrochloride |
| Active Ingredient(s): | 100; 100 mg/10g; mg/10g & nbsp; hydrocortisone acetate and pramoxine hydrochloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | AEROSOL, FOAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68220-144 |
| Labeler Name: | Alaven Pharmaceutical LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA086457 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19791219 |
| Package NDC: | 68220-144-10 |
| Package Description: | 1 CONTAINER in 1 CARTON (68220-144-10) > 10 g in 1 CONTAINER |
| NDC Code | 68220-144-10 |
| Proprietary Name | Epifoam |
| Package Description | 1 CONTAINER in 1 CARTON (68220-144-10) > 10 g in 1 CONTAINER |
| Product NDC | 68220-144 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hydrocortisone acetate and pramoxine hydrochloride |
| Dosage Form Name | AEROSOL, FOAM |
| Route Name | TOPICAL |
| Start Marketing Date | 19791219 |
| Marketing Category Name | ANDA |
| Labeler Name | Alaven Pharmaceutical LLC |
| Substance Name | HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE |
| Strength Number | 100; 100 |
| Strength Unit | mg/10g; mg/10g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |